CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 100/kg
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Fast Delivery
The supplier can deliver the goods within 15 days
Low MOQ
The MOQ for the supplier's products is 1
to see all verified strength labels (7)
  • CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
  • CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
  • CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
  • CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
  • CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
  • CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
Find Similar Products

Basic Info.

Model NO.
QH-Dtpa-Bma
Appearance
White
Sample
Available
Storage
Cool Dry Place
Shelf Life
2 Years
Transport Package
25kg/Drum
Specification
99%
Trademark
Qinhe
Origin
China
HS Code
0000
Production Capacity
99999kg/Weeks

Product Description

CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials

Gadolinium diamine is mainly used for:

Gadolinium is a colorless or yellowish clear liquid that is administered intravenously. It is mainly suitable for magnetic resonance imaging of the head, spinal cord and body after intravenous injection. After the use of gadolinium diamine injection, it can enhance the contrast and facilitate the display of different parts of the body, including the abnormal structure of the central nervous system. When using this drug, it must be noted that one tube of injection can only be used by one patient, and drugs that are not used up at one time should be discarded and not used twice.

2. Adverse reactions of gadolinium diamine:

Patients may experience adverse reactions during the use of gadolinium diamine inJ. The most common symptom is fever or chills at the injection site. Some patients may also experience dizziness, headaches, nausea, and decreased sense of smell and taste. Occasionally, patients experience drowsiness, paresthesia, visual disturbance, difficulty breathing, chest tightness, joint pain, or skin irritation. Most of these symptoms are mild and short-lived.
 

CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials

 

CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials
Analysi Specifications
Assay ≥99%
Appearance White
Loss on Drying ≤1.0%
Ash ≤1.0%
As ≤2.0ppm
Pb ≤2.0ppm
Insoluble impurity content ≤0.05%
Total Plate Count ≤1000 cfu/g
Yeast &. Mold ≤100 cfu/g
E.Coli Negative
Salmonella Negative
Conclusion
 
Conform USP Standard.
Storage condition
Store in cool & dry place, Keep away from strong light and heat.
Shelf life
2 years when properly stored.
CAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw MaterialsCAS 119895-95-3 Dtpa-Bma Pharmaceutical Raw Materials

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier